Clin Assess

For more than 22 years, Clin Assess is a CRO that pursue its work with great passion. They work on commercial studies including those with a high patient number.

Customers appreciate their medical background, their expertise, and the precision in which they achieve their goals and realise all phases of the clinical trial with pinpoint accuracy.

They rely on clear project communication with interactive feedback, provide individual support for their customers and accompany them step by step from the beginning and through all stages of the project.

Their employees are specialists from the pharmaceutical industry, contract research and the clinical sector. They have special expertise in the fields of oncology, cardiovascular diseases, infectious diseases, immunotherapy, personalised medicine and diseases of the central nervous system.

Learn more: www.clinassess.de

Back to CRO Alliance

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

LATEST NEWSOUR NEWS >

Deliberation No. 2026-051 of 19 March 2026 approving a reference methodology relating to the processing of personal data carried out in the context of health research that does not require the collection of the data subject’s consent for participation in the research (MR-003), and repealing Deliberation No. 2018-154

May 28, 2026

CNIL / Official Journal The French Data Protection Authority (CNIL), Having regard to Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General […]

Deliberation No. 2026-050 of 19 March 2026 approving a reference methodology relating to the processing of personal data carried out in the context of health research requiring the collection of the data subject’s consent for participation in the research (MR-001), and repealing Deliberation No. 2018-153

May 28, 2026

Sites Are Walking Away: Why Payment Experience is the New Competitive Advantage

April 30, 2026

Applied Clinical Trials Online Payment experience—including how, when, and with what level of transparency sites are compensated—is rapidly emerging as a defining factor in the success of clinical trials. Once dismissed as a simple operational nuisance, payments are now recognized as a critical component for shaping site relationships and study outcomes. For years, sites had […]